We are live on ! Find out more
CCM

Catapult Capital Management Portfolio holdings

AUM $265M
1-Year Est. Return 21.83%
This Fund
S&P 500
This Quarter Est. Return
+12.28%
1 Year Est. Return
+21.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$393M
AUM Growth
-$542M
Cap. Flow
-$571M
Cap. Flow %
-145.32%
Top 10 Hldgs %
27.78%
Holding
280
New
90
Increased
20
Reduced
43
Closed
125

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$10.7M
2
CVS icon
CVS Health
CVS
+$10.1M
3
MDT icon
Medtronic
MDT
+$10M
4
MD icon
Pediatrix Medical
MD
+$8.85M
5
PFE icon
Pfizer
PFE
+$8.68M

Sector Composition

Rank Sector Weight
1 Healthcare 45.46%
2 Industrials 11.94%
3 Consumer Discretionary 11.34%
4 Materials 4.24%
5 Technology 3.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHPG
1
DELISTED
Shire pic
SHPG
$14.3M 3.65%
67,500
+24,024
+55% +$5.1M
ARMK icon
2
Aramark
ARMK
$15.1B
$11.8M 3%
+523,849
New +$10.7M
PFE icon
3
Pfizer
PFE
$142B
$11.3M 2.87%
381,668
+302,618
+383% +$8.68M
CVS icon
4
CVS Health
CVS
$134B
$11M 2.8%
+114,246
New +$10.1M
TEVA icon
5
Teva Pharmaceuticals
TEVA
$41.2B
$10.9M 2.78%
190,000
+65,000
+52% +$3.62M
MDT icon
6
Medtronic
MDT
$110B
$10.4M 2.64%
+143,934
New +$10M
SPY icon
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$10.3M 2.61%
50,000
-300,000
-86% -$60.3M
MNK
8
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$9.9M 2.52%
100,000
+1
+0% +$92
BKD icon
9
Brookdale Senior Living
BKD
$3.49B
$9.72M 2.47%
265,000
+100,000
+61% +$3.39M
MD icon
10
Pediatrix Medical
MD
$2.17B
$9.59M 2.44%
+145,000
New +$8.85M
BHC icon
11
Bausch Health
BHC
$2.25B
$8.59M 2.18%
+60,000
New +$8.07M
HSP
12
DELISTED
HOSPIRA INC
HSP
$8.27M 2.1%
+135,000
New +$7.62M
ISRG icon
13
Intuitive Surgical
ISRG
$126B
$7.93M 2.02%
135,000
-45,000
-25% -$2.51M
WCG
14
DELISTED
Wellcare Health Plans, Inc.
WCG
$7.8M 1.98%
+95,000
New +$6.62M
GILD icon
15
Gilead Sciences
GILD
$163B
$7.68M 1.95%
+81,490
New +$8.43M
ELV icon
16
Elevance Health
ELV
$81.6B
$6.76M 1.72%
53,800
+3,800
+8% +$470K
THOR
17
DELISTED
THORATEC CORPORATION
THOR
$6.49M 1.65%
200,000
+150,000
+300% +$4.36M
DVA icon
18
DaVita
DVA
$15.3B
$6.06M 1.54%
80,000
-30,000
-27% -$2.26M
EW icon
19
Edwards Lifesciences
EW
$50B
$5.73M 1.46%
270,000
+120,000
+80% +$2.41M
HCA icon
20
HCA Healthcare
HCA
$85.7B
$5.5M 1.4%
75,000
-25,000
-25% -$1.76M
DHR icon
21
Danaher
DHR
$138B
$5.13M 1.31%
89,102
+20,117
+29% +$1.09M
RAD
22
DELISTED
Rite Aid Corporation
RAD
$4.89M 1.24%
+32,500
New +$3.61M
AMAG
23
DELISTED
AMAG Pharmaceuticals
AMAG
$4.69M 1.19%
110,000
+5,000
+5% +$181K
PPG icon
24
PPG Industries
PPG
$24.9B
$4.38M 1.11%
37,890
+15,240
+67% +$1.58M
HSIC icon
25
Henry Schein
HSIC
$9.7B
$4.08M 1.04%
+76,500
New +$3.81M

Similar funds

Catapult Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Catapult Capital Management held 280 positions worth $393M, down 58% from $935M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Catapult Capital Management withdrew a net $571M in Q4 2014, closing 125 positions and reducing 43 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $31.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Catapult Capital Management opened a new position in Aramark worth $11.8M.

  • Catapult Capital Management's largest Q4 2014 buy was Aramark: 523,849 shares worth $11.8M.
  • Catapult Capital Management added most to Pfizer in Q4 2014, an estimated $8.68M increase.
  • Catapult Capital Management's biggest Q4 2014 reduction was PepsiCo, cutting an estimated $12.8M.
  • Catapult Capital Management fully exited TIME WARNER CABLE INC NEW COM STK in Q4 2014, selling an estimated $31.4M.
  • Catapult Capital Management's ten largest holdings make up 28% of its $393M portfolio in Q4 2014.
  • Catapult Capital Management opened 90 new positions and closed 125 in Q4 2014.
  • Catapult Capital Management's portfolio value fell 58% quarter-over-quarter to $393M.

Based on Catapult Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.